BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 20797521)

  • 1. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
    Bergman R
    Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous pseudolymphomas: classification and differential diagnosis.
    Rijlaarsdam JU; Willemze R
    Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
    Cerroni L; Goteri G
    Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
    Rijlaarsdam JU; Willemze R
    Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneus pseudolymphoma: a case report.
    Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A
    In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
    Levy E; Godet J; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced number of CD1a+ cells in cutaneous B-cell lymphoma.
    Schmuth M; Sidoroff A; Danner B; Topar G; Sepp NT
    Am J Clin Pathol; 2001 Jul; 116(1):72-8. PubMed ID: 11447755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
    Lan TT; Brown NA; Hristov AC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Item 164--Malignant lymphomas: cutaneous lymphomas].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic signs of cutaneous lymphomas.
    Burg G; Kempf W; Dummer R
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):358-60. PubMed ID: 11730054
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects in the classification of cutaneous lymphomas].
    Erós N; Károlyi Z; Kovács A
    Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
    Magro CM; Momtahen S
    Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
    Kempf W; Dummer R; Burg G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
    Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
    Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.
    Kerl H; Fink-Puches R; Cerroni L
    Keio J Med; 2001 Dec; 50(4):269-73. PubMed ID: 11806505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of the significance of histological, immunohistochemical and clinical data in the diagnosis of lymphoproliferative skin diseases in conformance with a consensus by international experts].
    Belousova IIe; Kazakov DV; Samtsov AV; Kempf W
    Arkh Patol; 2004; 66(2):11-6. PubMed ID: 15154375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cutaneous lymphomas].
    Schad K; Baumann Conzett K; Cozzio A
    Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.